Filing Details

Accession Number:
0001179110-17-012351
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-18 11:16:50
Reporting Period:
2017-09-13
Accepted Time:
2017-09-18 11:16:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
855654 Immunogen Inc IMGN Pharmaceutical Preparations (2834) 042726691
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1691868 Anna Berkenblit C/O Immunogen, Inc.
830 Winter Street
Waltham MA 02152
Vp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-09-13 1,500 $7.00 161,800 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct